Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Carroll

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Urologic Oncology|September 12, 2006
Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURECharles J Ryan, Eric P Elkin, Eric J Small, et al.
Urology|February 5, 2008
Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortalityChristine S Chung, Ming-Hui Chen, Jennifer Cullen, et al.
Drugs & Aging|January 24, 2014
Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort studyAlexander Bennett, Danijela Gnjidic, Mark Gillett, et al.
Clinical Genitourinary Cancer|December 5, 2019
Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer RegistryRenske M T Ten Ham, Jeanette M Broering, Matthew R Cooperberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancerPamela L Paris, Vivian Weinberg, Giancarlo Albo, et al.
The Prostate|May 10, 2005
Ethnic and racial differences in prostate stromal estrogen receptor alphaChristopher Haqq, Rile Li, Daniel Khodabakhsh, et al.
BMC Medicine|November 28, 2015
Who and when should we screen for prostate cancer? Interviews with key opinion leadersSigrid Carlsson, Michael Leapman, Peter Carroll, et al.
Urology|January 18, 2006
Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillanceJennifer J Daubenmier, Gerdi Weidner, Ruth Marlin, et al.
European Urology|January 21, 2014
Overdiagnosis and overtreatment of prostate cancerStacy Loeb, Marc A Bjurlin, Joseph Nicholson, et al.
American Journal of Clinical Oncology|January 21, 2014
Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without SurgeryGilles Crehange, Alejandra Izaguirre, Vivian Weinberg, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Urologic Oncology|September 12, 2006
Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURECharles J Ryan, Eric P Elkin, Eric J Small, et al.
Urology|February 5, 2008
Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortalityChristine S Chung, Ming-Hui Chen, Jennifer Cullen, et al.
Drugs & Aging|January 24, 2014
Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort studyAlexander Bennett, Danijela Gnjidic, Mark Gillett, et al.
Clinical Genitourinary Cancer|December 5, 2019
Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer RegistryRenske M T Ten Ham, Jeanette M Broering, Matthew R Cooperberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancerPamela L Paris, Vivian Weinberg, Giancarlo Albo, et al.
The Prostate|May 10, 2005
Ethnic and racial differences in prostate stromal estrogen receptor alphaChristopher Haqq, Rile Li, Daniel Khodabakhsh, et al.
BMC Medicine|November 28, 2015
Who and when should we screen for prostate cancer? Interviews with key opinion leadersSigrid Carlsson, Michael Leapman, Peter Carroll, et al.
Urology|January 18, 2006
Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillanceJennifer J Daubenmier, Gerdi Weidner, Ruth Marlin, et al.
European Urology|January 21, 2014
Overdiagnosis and overtreatment of prostate cancerStacy Loeb, Marc A Bjurlin, Joseph Nicholson, et al.
American Journal of Clinical Oncology|January 21, 2014
Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without SurgeryGilles Crehange, Alejandra Izaguirre, Vivian Weinberg, et al.
Pageof 8